Rubicon Research IPO: Pharma firm raises ₹619 crore from anchor investors ahead of public issue — Details here

Rubicon Research IPO: Pharmaceutical company Rubicon Research completed its anchor investor round on Wednesday, 8 October 2025. The firm raised ₹619 crore from the anchor investors ahead of its initial public offering (IPO).

Rubicon Research allocated a total of 1,27,64,691 or more than 1.27 crore equity shares with a face value of Re 1 apiece to the anchor investors at an allocation price of ₹485 per share, the company informed BSE through a filing.

Out of the total anchor allocation for the public issue, equity shares were allocated to eight domestic mutual funds through a total of 18 schemes.

HDFC Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mahindra Mutual Fund, Canara Robeco Mutual Fund, and Mirae Asset Mutual Fund were among the other Indian mutual funds.

Fidelity Funds – India Focus Fund, Nomura Funds Ireland – India Equity Fund, Goldman Sachs Funds – India Equity Portfolio, Aranda Investments Pte. Ltd., and Amansa Holdings Private Limited were among the marquee investors who invested in the company's anchor round ahead of the IPO.

Rubicon Research IPO latest GMP

As of Wednesday, 8 October 2025, the grey market premium (GMP) of the Rubicon Research IPO stands at ₹80 per share. With the upper price band of the public issue at ₹485, the company's shares are expected to be listed at ₹565 apiece, marking a premium of 16%, according to IPO India data.

The grey market premium (GMP) is the investors' willingness to pay more for a primary issue in the stock market.

Rubicon Research IPO details

Rubicon Research is offering a book-built issue comprising a fresh issue of equity shares with the face value of Re 1 per share, amounting to ₹500 crore, along with an offer for sale (OFS) component of shares amounting to ₹877.49 crore.

The company aims to raise ₹1,377.49 crore from the Indian stock market via the initial public offering (IPO). The IPO is set to open for public bidding on Thursday, 9 October 2025, and is scheduled to close after its final bidding round on Monday, 13 October 2025.

The company fixed the price band of the IPO in the range of ₹461 to ₹485 per share with a lot size of 30 shares per lot.

Axis Capital Ltd, JM Financial Limited, SBI Capital Markets Limited and IIFL Capital Services Limited are the book-running lead managers of the public issue, while MUFG Intime India Pvt. Ltd is the registrar of the offer.

Read all IPO news here

Read all stories by Anubhav Mukherjee

Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.